90 related articles for article (PubMed ID: 4737044)
1. Carcinoembryonic antigen (CEA) in the plasma and urine of patients with urologic cancer.
Thitipraserth A; Ablin R; Bush I; Guinan P
Proc Inst Med Chic; 1973; 29(9):323. PubMed ID: 4737044
[No Abstract] [Full Text] [Related]
2. The carcinoembryonic antigen test in urologic cancer.
Guinan PD; McKiel C; Sundar B; Veith R; Dubin A; Ablin RJ
Natl Cancer Inst Monogr; 1978 Dec; (49):225-9. PubMed ID: 748773
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen and urothelial carcinoma.
Hall RR; Laurence DJ; Neville AM; Wallace DM
Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
[No Abstract] [Full Text] [Related]
4. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
Hering H; Hering FJ; Weidner W
Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
6. Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
Coombers GB; Hall RR; Laurence JR; Neville AM
Br J Cancer; 1975 Feb; 31(2):135-42. PubMed ID: 1164465
[TBL] [Abstract][Full Text] [Related]
7. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
Björklund V; Björklund B
Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
[TBL] [Abstract][Full Text] [Related]
8. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
[No Abstract] [Full Text] [Related]
9. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
[TBL] [Abstract][Full Text] [Related]
10. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
11. A B O (H) blood group antigen determination in genitourinary neoplasms.
Ghazizadeh M; Kagawa S
Tokushima J Exp Med; 1983 Jun; 30(1-2):9-16. PubMed ID: 6685361
[No Abstract] [Full Text] [Related]
12. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
[TBL] [Abstract][Full Text] [Related]
13. [Immunological evaluation in urologic tumors].
Glait HM; Scorticati C; Feierstein JN; Bellora O; Koss A; Olivari JA
Arch Esp Urol; 1981; 34(6):437-60. PubMed ID: 6177291
[No Abstract] [Full Text] [Related]
14. Carcinoembryonic antigen. Current clinical status.
Chu TM; Holyoke ED; Murphy GP
N Y State J Med; 1974 Jul; 74(8):1388-93. PubMed ID: 4604186
[No Abstract] [Full Text] [Related]
15. [Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].
Adolphs HD; Oehr P
Helv Chir Acta; 1982 Aug; 49(3-4):307-11. PubMed ID: 7129893
[No Abstract] [Full Text] [Related]
16. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
Lüthgens M; Schlegel G
Cancer Detect Prev; 1983; 6(1-2):51-9. PubMed ID: 6883393
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
19. [Determination of carcinoembryonic antigen in urine and in gastric secretions].
Menduni P; Di Sciascio G; Lisanti A; Caracino A
Minerva Med; 1983 Nov; 74(44):2671-5. PubMed ID: 6657117
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.
Gajda M; Tyloch F; Jóźwicki W; Tyloch J; Sujkowska R; Skok Z
Int J Occup Med Environ Health; 1995; 8(2):103-8. PubMed ID: 7582848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
